A detailed history of Lex Aurum Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Lex Aurum Advisors, LLC holds 26,786 shares of PFE stock, worth $715,721. This represents 0.18% of its overall portfolio holdings.

Number of Shares
26,786
Previous 12,586 112.82%
Holding current value
$715,721
Previous $352,000 120.17%
% of portfolio
0.18%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$27.7 - $31.39 $393,340 - $445,738
14,200 Added 112.82%
26,786 $775,000
Q2 2024

Jul 15, 2024

BUY
$25.26 - $29.6 $9,851 - $11,544
390 Added 3.2%
12,586 $352,000
Q1 2024

Apr 10, 2024

BUY
$25.89 - $29.73 $40,828 - $46,884
1,577 Added 14.85%
12,196 $338,000
Q4 2023

Jan 10, 2024

SELL
$26.13 - $33.94 $9,328 - $12,116
-357 Reduced 3.25%
10,619 $305,000
Q3 2023

Oct 16, 2023

SELL
$32.09 - $37.51 $129,675 - $151,577
-4,041 Reduced 26.91%
10,976 $364,000
Q2 2023

Jul 25, 2023

BUY
$36.12 - $41.79 $136,533 - $157,966
3,780 Added 33.64%
15,017 $550,000
Q1 2023

Apr 11, 2023

SELL
$39.39 - $51.28 $15,322 - $19,947
-389 Reduced 3.35%
11,237 $458,000
Q4 2022

Jan 23, 2023

BUY
$41.75 - $54.5 $10,813 - $14,115
259 Added 2.28%
11,626 $0
Q3 2022

Oct 17, 2022

BUY
$43.76 - $53.42 $3,982 - $4,861
91 Added 0.81%
11,367 $497,000
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $23,032 - $27,309
-495 Reduced 4.21%
11,276 $591,000
Q1 2022

May 04, 2022

SELL
$45.75 - $56.69 $52,383 - $64,910
-1,145 Reduced 8.86%
11,771 $609,000
Q4 2021

Jan 24, 2022

SELL
$41.32 - $61.25 $9,462 - $14,026
-229 Reduced 1.74%
12,916 $763,000
Q3 2021

Nov 03, 2021

SELL
$39.25 - $50.42 $2,786 - $3,579
-71 Reduced 0.54%
13,145 $565,000
Q2 2021

Jul 19, 2021

BUY
$35.91 - $40.68 $88,697 - $100,479
2,470 Added 22.99%
13,216 $518,000
Q1 2021

Apr 22, 2021

BUY
$33.49 - $37.77 $15,472 - $17,449
462 Added 4.49%
10,746 $389,000
Q4 2020

Jan 20, 2021

BUY
$33.47 - $42.56 $2,142 - $2,723
64 Added 0.63%
10,284 $379,000
Q3 2020

Oct 22, 2020

BUY
$31.75 - $37.25 $27,114 - $31,811
854 Added 9.12%
10,220 $375,000
Q2 2020

Jul 22, 2020

BUY
$30.12 - $36.54 $1,686 - $2,046
56 Added 0.6%
9,366 $306,000
Q1 2020

Apr 22, 2020

BUY
$27.03 - $38.62 $27,381 - $39,122
1,013 Added 12.21%
9,310 $304,000
Q4 2019

Jan 27, 2020

BUY
$32.92 - $37.36 $25,085 - $28,468
762 Added 10.11%
8,297 $325,000
Q3 2019

Oct 17, 2019

BUY
$32.49 - $42.13 $97 - $126
3 Added 0.04%
7,535 $271,000
Q2 2019

Jul 19, 2019

SELL
$36.98 - $41.52 $332 - $373
-9 Reduced 0.12%
7,532 $326,000
Q1 2019

May 03, 2019

BUY
$37.5 - $41.2 $16,987 - $18,663
453 Added 6.39%
7,541 $320,000
Q4 2018

Feb 07, 2019

BUY
$38.47 - $43.86 $538 - $614
14 Added 0.2%
7,088 $309,000
Q3 2018

Nov 09, 2018

SELL
$34.47 - $41.81 $13,477 - $16,347
-391 Reduced 5.24%
7,074 $312,000
Q2 2018

Aug 07, 2018

BUY
$32.98 - $35.16 $98 - $105
3 Added 0.04%
7,465 $271,000
Q1 2018

May 09, 2018

SELL
$31.91 - $37.02 $37,749 - $43,794
-1,183 Reduced 13.68%
7,462 $265,000
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $287,532 - $305,082
8,645
8,645 $316,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lex Aurum Advisors, LLC Portfolio

Follow Lex Aurum Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lex Aurum Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lex Aurum Advisors, LLC with notifications on news.